Duane E. Johnson

2.2k total citations
41 papers, 1.8k citations indexed

About

Duane E. Johnson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Duane E. Johnson has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Genetics and 10 papers in Oncology. Recurrent topics in Duane E. Johnson's work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Duane E. Johnson is often cited by papers focused on Virus-based gene therapy research (14 papers), Cancer Research and Treatments (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Duane E. Johnson collaborates with scholars based in United States, United Kingdom and Czechia. Duane E. Johnson's co-authors include Otto Z. Sellinger, Ken N. Wills, Robert O. Dillman, Daniel L. Shawler, G W Demers, Daniel C. Maneval, Suganto Sutjipto, H. Michael Shepard, Richard J. Gregory and Shu Fen Wen and has published in prestigious journals such as Journal of the American Chemical Society, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Duane E. Johnson

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duane E. Johnson United States 21 974 647 611 338 237 41 1.8k
J A Barbosa United States 21 1.4k 1.4× 852 1.3× 297 0.5× 77 0.2× 317 1.3× 30 2.4k
Adam P. Silverman United States 21 2.3k 2.4× 353 0.5× 1.4k 2.2× 239 0.7× 185 0.8× 36 3.2k
Lou de Leij Netherlands 23 1.0k 1.1× 196 0.3× 483 0.8× 76 0.2× 377 1.6× 51 1.9k
Meera Iyer United States 24 1.7k 1.8× 1.4k 2.1× 401 0.7× 366 1.1× 579 2.4× 39 2.9k
Karsten Brand Germany 24 1.4k 1.5× 395 0.6× 1.1k 1.7× 183 0.5× 106 0.4× 45 2.5k
Alex Matter Switzerland 17 941 1.0× 204 0.3× 410 0.7× 64 0.2× 136 0.6× 36 2.1k
Raymond E. Jones United States 25 1.7k 1.7× 311 0.5× 628 1.0× 56 0.2× 91 0.4× 40 2.6k
Batya Cohen Israel 22 943 1.0× 184 0.3× 506 0.8× 76 0.2× 281 1.2× 34 2.3k
Steven J. Weintraub United States 17 1.2k 1.3× 253 0.4× 920 1.5× 78 0.2× 57 0.2× 34 1.9k
Timothy J. Jorgensen United States 24 1.5k 1.5× 319 0.5× 798 1.3× 68 0.2× 137 0.6× 53 2.2k

Countries citing papers authored by Duane E. Johnson

Since Specialization
Citations

This map shows the geographic impact of Duane E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duane E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duane E. Johnson more than expected).

Fields of papers citing papers by Duane E. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duane E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duane E. Johnson. The network helps show where Duane E. Johnson may publish in the future.

Co-authorship network of co-authors of Duane E. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Duane E. Johnson. A scholar is included among the top collaborators of Duane E. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duane E. Johnson. Duane E. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahmed, C. M. Iqbal, Ken N. Wills, Barry J. Sugarman, et al.. (2001). Selective Expression of Nonsecreted Interferon by an Adenoviral Vector Confers Antiproliferative and Antiviral Properties and Causes Reduction of Tumor Growth in Nude Mice. Journal of Interferon & Cytokine Research. 21(6). 399–408. 27 indexed citations
3.
Atencio, Isabella, Jenny B. Avanzini, Duane E. Johnson, et al.. (2001). Enhanced Apoptotic Activity of a p53 Variant in Tumors Resistant to Wild-Type p53 Treatment. Molecular Therapy. 4(1). 5–12. 7 indexed citations
4.
Ahmed, C. M. Iqbal, Duane E. Johnson, G W Demers, et al.. (2001). Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers. Cancer Gene Therapy. 8(10). 788–795. 33 indexed citations
5.
Ramachandra, Murali, Amena Rahman, Aihua Zou, et al.. (2001). Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy. Nature Biotechnology. 19(11). 1035–1041. 113 indexed citations
6.
Howe, John, et al.. (2001). Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer Therapy. Molecular Therapy. 3(2). 276–276.
7.
Wills, Ken N., Isabella Atencio, Jenny B. Avanzini, et al.. (2001). Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant Adenovirus. Journal of Virology. 75(18). 8733–8741. 44 indexed citations
8.
Howe, John, G W Demers, Duane E. Johnson, et al.. (2000). Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer Therapy. Molecular Therapy. 2(5). 485–495. 62 indexed citations
9.
Ahmed, C. M. Iqbal, et al.. (1999). In Vivo Tumor Suppression by Adenovirus-Mediated Interferon alpha2b Gene Delivery. Human Gene Therapy. 10(1). 77–84. 21 indexed citations
10.
11.
Wills, Ken N., Daniel C. Maneval, Patricia Menzel, et al.. (1994). Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer. Human Gene Therapy. 5(9). 1079–1088. 204 indexed citations
12.
Shawler, Daniel L., et al.. (1988). Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101. Clinical Immunology and Immunopathology. 47(2). 219–229. 15 indexed citations
13.
Dillman, Robert O., Duane E. Johnson, Daniel L. Shawler, & Jim Koziol. (1988). Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.. PubMed. 48(21). 6097–102. 58 indexed citations
14.
Dillman, Robert O., Daniel L. Shawler, Duane E. Johnson, et al.. (1986). Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin.. PubMed. 46(10). 4886–91. 52 indexed citations
15.
Johnson, Duane E., et al.. (1980). Togavirus infection in rural Thailand.. PubMed. 11(2). 184–8. 3 indexed citations
16.
Pacansky, J. & Duane E. Johnson. (1977). Photochemical Studies on a Substituted Naphthalene‐2,1,Diazooxide: The Formation and Identification of a Ketene from a Wolff Rearrangement. Journal of The Electrochemical Society. 124(6). 862–865. 18 indexed citations
17.
Dmochowski, L., Y Ohtsuki, G Seman, et al.. (1977). Search for oncogenic viruses in human prostate cancer.. PubMed. 61(2). 119–27. 6 indexed citations
18.
Johnson, Duane E., et al.. (1976). Histologic Factors Affecting Prognosis of Pure Seminoma of the Testis*. Southern Medical Journal. 69(9). 1173–1174. 7 indexed citations
19.
Johnson, Duane E. & Otto Z. Sellinger. (1973). Synthesis of soluble neuronal proteins in vivo. Age-dependent differences in the incorporation of leucine and phenylalanine. Brain Research. 54. 129–142. 3 indexed citations
20.
Sellinger, Otto Z., Julio M. Azcurra, Duane E. Johnson, W. G. Ohlsson, & Z Lodin. (1971). Independence of Protein Synthesis and Drug Uptake in Nerve Cell Bodies and Glial Cells isolated by a New Technique. Nature New Biology. 230(16). 253–256. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J A Barbosa Breakdown of academic impact, for papers by Adam P. Silverman Breakdown of academic impact, for papers by Lou de Leij Breakdown of academic impact, for papers by Meera Iyer Breakdown of academic impact, for papers by Karsten Brand Breakdown of academic impact, for papers by Alex Matter Breakdown of academic impact, for papers by Raymond E. Jones Breakdown of academic impact, for papers by Batya Cohen Breakdown of academic impact, for papers by Steven J. Weintraub Breakdown of academic impact, for papers by Timothy J. Jorgensen
Rankless by CCL
2026